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Abstract
Background: MicroRNAs (miRNAs) have been regarded as a critical factor in targeting oncogenes or tumor suppressor
genes in tumorigenesis. The genetic predisposition of miRNAs-signaling pathways related to the development of oral
squamous cell carcinoma (OSCC) remains unresolved. This study examined the associations of polymorphisms with four
miRNAs with the susceptibility and clinicopathological characteristics of OSCC.
Methodology/Principal Findings: A total of 895 male subjects, including 425 controls and 470 male oral cancer patients,
were selected. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and real-time PCR were
used to analyze miRNA146a, miRNA196, miRNA499 and miRNA149 genetic polymorphisms between the control group and
the case group. This study determined that a significant association of miRNA499 with CC genotype, as compared to the
subjects with TT genotype, had a higher risk (AOR=4.52, 95% CI=1.24–16.48) of OSCC. Moreover, an impact of those four
miRNAs gene polymorphism on the susceptibility of betel nut and tobacco consumption leading to oral cancer was also
revealed. We found a protective effect between clinical stage development (AOR=0.58, 95% CI=0.36–0.94) and the tumor
size growth (AOR=0.47, 95% CI=0.28–0.79) in younger patients (age,60).
Conclusions: Our results suggest that genetic polymorphism of miRNA499 is associated with oral carcinogenesis, and the
interaction of the miRNAs genetic polymorphism and environmental carcinogens is also related to an increased risk of oral
cancer in Taiwanese.
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Introduction
MircoRNAs (miRNAs) are small fragment RNAs, which
contain approximately 20–22 nucleotides, can target specific
mRNAs and negatively regulate their translational efficiency and
stability [1]. Previous findings have shown that one miRNA could
influence expression of several target genes. According to
regulating different target RNAs, miRNAs can participate in
cellular processes including proliferation, differentiation, and
survival [2]. Altered miRNA expression has been observed in
several diseases, especially in cancer [3].
In Taiwan, oral cancer is the fourth most common cancer
among men. A rapid increase of incidence of oral cancer occurred
in the past few years and crude mortality rate of oral cancer was
10.1 per 100,000 in 2007 and ranked as the sixth cause of cancer
death [4]. In the past few years, incidence of oral cancer was
particularly high in South Asia. This phenomenon appears
especially in populations accustomed to chewing areca (betel)
nut [5]. Epidemiological studies have also suggested that the
susceptibility of oral cancer is mediated by both environmental
carcinogens (including alcohol intake, tobacco consumption, and
betel nut chewing) and genetic factors [6]. Increasingly more
evidence shows that miRNAs are associated with head and neck/
oral cancer [7], and several miRNAs have been shown to be
unregulated in head and neck cancer [8]. This relationship has
also been determined in laboratory research [9].
Single nucleotide polymorphism (SNP) is a variation in the
DNA sequence that occurs when nucleotides (A, T, C or G)
change in at least 1% of a certain population. Some epidemiologic
evidence shows that miRNA genetic variations are associated with
progression to oral cancer [10,11]. While miRNAs have received
considerable attention in recent years, SNPs in miRNA and pre-
miRNA sequences have been discovered to be connected to their
candidate genes [12]. In dbSNP database, over 400 miRNAs
SNPs have been documented. To obtain adequate power for
evaluating the potential association, we investigated miRNA146a
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and miRNA499 (rs3746444), those with minor allele frequencies
$5% and also located at the pre-miRNA regions in the Chinese
populations [13,14]. In another aspect, these four miRNA SNPs
have been reported as important for tumorigenesis due to their
targeting on several important genes [15]. Therefore, these four
miRNA SNPs were selected in this study. We also considered a
unique phenomenon in South Asia, where most oral cancer
individuals have a betel nut chewing habit. We combined clinical
status and laboratory outcomes to determine the relationship
between these SNPs and the susceptibility of oral cancer.
Results
The statistical analysis of demographic characteristics is shown
in Table 1. There were significant differences in the distributions
of betel-quid chewing (p,0.001), alcohol consumption (p,0.001),
and tobacco use (p,0.001) between healthy control subjects and
OSCC patients. Because these differences between the two groups
may be confounders, we adjusted these characteristics in further
statistical analysis.
The distribution of miRNA SNP genotypes are described in
Table 2. In our healthy controls, miRNA polymorphisms
(rs2910164, rs11614913, and rs3746444) conformed to the
Hardy-Weinberg equilibrium, except for rs2292832 (p,0.001).
We used logistic regression model to estimate the adjusted odds
ratios (AORs). After adjusting age, smoking status, alcohol intake
and betel nut chewing habits, we found that miRNA499 CC
genotypes exhibited significantly (p,0.05) higher risks of
4.522(95% CI=1.24–16.48) of having OSCC compared to the
corresponding wild-type (WT) homozygotes. However, there was
no significantly higher oral cancer risk for individuals with the
miRNA146a, miRNA149 and miRNA196 polymorphic gene
compared to those with the WT gene.
Considering that risk factors such as betel nut chewing may
modify the genetic susceptibility to oral cancer, and the interactive
effects between environmental risk factors and genetic polymor-
phisms of miRNAs are shown in Table 3, Table S1 and Table S2.
Subjects with at least one C allele of miRNA499 and a betel nut-
chewing habit had respective higher risks of 17.332(95%
CI=9.63–31.17) of having oral cancer (Table 3). Subjects with
at least one G allele of miRNA146a, the C allele of miRNA149, or
the C allele of miRNA196, and a betel nut-chewing habit had
respective higher risks of 9.932(95% CI=6.01–16.41),
8.672(95% CI=5.06–14.89), and 10.982(95% CI=6.21–19.39)
of having oral cancer (Table S1). Similarly, tobacco consumption
significantly elevated the oral cancer risk in subjects polymorphic
for miRNA146a, miRNA149, miRNA196 and miRNA499
compared to individuals with the WT gene but without smoking
(Table 3 and Table S2). We further evaluated the gene-
environment statistical interaction between the miRNA polymor-
phisms, smoking and betel quid on oral cancer (Table 3, Table S1
and Table S2). Statistical significance was found for the interaction
between all miRNA polymorphisms, smoking and betel quid on
oral cancer development (p,0.05). The above results suggest that
miRNAs gene polymorphisms have a strong impact on oral cancer
susceptibility in betel nut and/or smoking consumers.
To explore the impacts of polymorphic genotypes of miRNAs
on the clinical status of OSCC, we further classified OSCC
patients into two subgroups: one subgroup with at least one
polymorphic allele, and the other subgroup with homozygous WT
Table 1. Demographical characteristics in 425 healthy
controls and 470 patients with oral cancer.
Characteristic Control Oral cancer Total p value
N=425 (%) N=470 (%) N=895 (%)
Age
#60 307 (72.21) 332 (70.64) 639 (71.40) 0.279
.60 118 (27.79) 138 (29.36) 256 (28.60)
Smoking status
Yes 202 (47.53) 409 (87.02) 611 (68.27) ,0.001
No 223 (52.47) 61 (12.98) 284 (31.73)
Alcohol intake
Yes 185 (43.53) 295 (62.77) 480 (53.63) ,0.001
No 240 (56.47) 175 (37.23) 415 (46.37)
Betel nut chewing
Yes 90 (21.18) 371 (78.94) 461 (51.51) ,0.001
No 335 (78.82) 99 (21.06) 434 (48.49)
doi:10.1371/journal.pone.0039777.t001
Table 2. Distribution of miRNA genotypes in healthy controls
and oral cancer patients.
Gene Control Case OR AOR
a
N=425 (%)N=470 (%)(95% CI) (95% CI)
miRNA146a
rs2910164
CC 175 (41.18) 174 (37.02) Reference Reference
CG 196 (46.12) 242 (51.49) 1.24 (0.94–1.65) 1.18 (0.82–1.70)
GG 54 (12.70) 54 (11.49) 1.01 (0.66–1.55) 0.59 (0.32–1.08)
C allele 546 (64.24) 590 (62.77) Reference Reference
G allele 304 (35.76) 350 (37.23) 1.07 (0.88–1.29) 0.91 (0.71–1.17)
miRNA149
rs2292832
TT 315 (74.23) 345 (73.40) Reference Reference
CT 84 (19.75) 88 (18.72) 0.96 (0.68–1.34) 0.76 (0.49–1.17)
CC 26 (6.12) 37 (7.88) 1.30 (0.77–2.20) 1.45 (0.75–2.83)
T allele 714 (84.00) 778 (82.77) Reference Reference
C allele 136 (16.00) 162 (17.23) 1.09 (0.85–1.40) 1.02 (0.74–1.41)
miRNA196
rs11614913
TT 132 (31.06) 136 (28.94) Reference Reference
CT 206 (48.47) 277 (58.94) 1.31 (0.97–1.76) 1.14 (0.78–1.68)
CC 87 (20.47) 57 (12.12) 0.64 (0.42–0.96)* 0.74 (0.42–1.30)
T allele 470 (55.29) 549 (58.40) Reference Reference
C allele 380 (44.71) 391 (41.60) 0.88 (0.73–1.06) 0.92 (0.72–1.17)
miRNA499
rs3746444
TT 356 (83.76) 339 (72.13) Reference Reference
CT 66 (15.53) 119 (25.32) 1.89 (1.35–2.65)* 1.79 (1.16–2.75)*
CC 3 (0.71) 12 (2.55) 4.20 (1.18–15.02)* 4.52 (1.24–16.48)*
T allele 778 (91.53) 797 (84.79) Reference Reference
C allele 72 (8.47) 143 (15.21) 1.94 (1.44–2.62)* 1.81 (1.23–2.65)*
a.AOR adjusted, age, smoking status, alcohol intake and betel nut chewing.
*p,0.05.
doi:10.1371/journal.pone.0039777.t002
MicroRNA Gene Polymorphisms in Oral Cancer
PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e39777alleles. Data of the statistical analysis showed that who have
polymorphic miRNA499 gene had a protective effect of the tumor
size growth (AOR=0.46, 95% CI=0.29–0.72) as compared to
the patients with wild type (Table 4). However, no significant
association between miRNA416a, miRNA149 and miRNA196
gene polymorphisms and the clinicopathologic covariates were
observed (data not shown). Moreover, compared to the WT
genotype (T/T), patients with at least one polymorphic C allele of
miRNA499 showed a protective effect between clinical stage
development (AOR=0.58, 95% CI=0.36–0.94) and the tumor
size growth (AOR=0.47, 95% CI=0.28–0.79), in younger
patients (age#60), as shown in Table S3. However, no significant
association between miRNA499 gene polymorphisms and the
clinicopathologic covariates were observed in elderly patients
(age.60) (Table S4).
Discussion
In this study, we provided novel information of SNPs of
miRNA499 on the association of the oral cancer susceptibility.
After combining the major risk factor of oral cancer, these genetic
affects can also increase the susceptibility of oral cancer.
Considering previous findings, miRNA499 has been determined
to exhibit high expression in heart and skeletal muscle tissues [16].
Particularly in the heart, previous studies have also found that high
expression of miRNA499 increases the risk of cardiomyocyte
hypertrophy and cardiomyopathy. Furthermore, some evidence
suggests that miRNA499 can regulate mitochondrial dynamics
Table 3. Association of miRNA 499 genotype and betel nut chewing and smoking status.
Variable Control Case OR AOR
a
N=425 (%) N=470 (%) (95% CI) (95% CI)
TT and non-chewing 283 (66.59) 75 (15.96) Reference Reference
CT or CC or consumer 125 (29.41) 288 (61.28) 8.69 (6.25–12.09)* 5.95 (4.20–8.44)*
CT or CC with betel nut chewing 17 (4.00) 107 (22.77) 23.75 (13.41–42.06)* 17.33 (9.63–31.17)*
Test for interaction x
2=31.28 (1 d.f.), p,0.001*
Variable Control Case OR AOR
b
N=425 (%) N=470 (%) (95% CI) (95% CI)
TT and non-smoker 185 (43.53) 40 (8.51) Reference Reference
CT or CC or smoker 209 (49.18) 320 (68.09) 7.08 (4.83–10.39)* 3.03 (1.95–4.70)*
CT or CC with smoking 31 (7.29) 110 (23.40) 16.41 (9.71–27.74)* 6.31 (3.42–11.65)*
Test for interaction x
2=5.30 (1 d.f.), p=0.02*
a.AOR adjusted, age, smoking status and alcohol intake.
b.AOR adjusted, age, alcohol intake and betel nut chewing.
*p,0.05.
doi:10.1371/journal.pone.0039777.t003
Table 4. Relationship of clinical status and miRNA499 genotypes in oral cancer patients.
Gene TT CT/CC OR AOR
a
N=339 N=131 (95% CI) (95% CI)
Clinical Stage
Stage I+II 143 (42.18) 69 (52.67) Reference Reference
Stage III+IV 196 (57.82) 62 (47.33) 0.66(0.44–0.98)* 0.66 (0.44–1.00)
Tumor Size
T1+T2 195 (57.23) 98 (74.81) Reference Reference
T3+T4 145 (42.77) 33 (25.19) 0.45(0.29–0.71)* 0.46 (0.29–0.72)*
Lymph node metastasis
Negative 215 (63.42) 88 (67.18) Reference Reference
Positive 124 (36.58) 43 (32.82) 0.85 (0.55–1.30) 0.86 (0.56–1.32)
Cell differentiation
Well differentiated 46 (13.57) 20 (15.27) Reference Reference
Moderately or poorly differentiated 293 (86.43) 110 (84.73) 0.87 (0.49–1.54) 0.87 (0.49–1.54)
a.AOR adjusted, age, smoking status, alcohol intake and betel nut chewing.
*p,0.05.
doi:10.1371/journal.pone.0039777.t004
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studies have also shown that miRNA499 is highly associated with
heart diseases by regulate cellular differentiation and proliferation
[18,19]. These findings show that miRNA499 is possibly
associated with heart diseases and also carcinogenesis.
Based on the clinical status, previous studies have found that
miRNA-486, miRNA-30d, miRNA-1, and miRNA-499 exhibited
high expression in serum and were also associated with survival in
non-small-cell lung cancer [20]. Other studies have found that the
genetic variant in pre-miRNA may contribute to the process of
carcinogenesis in breast cancer [14,21], gastric cancer [22],
cervical cancer [23,24], and head and neck cancer [15]. In this
study, we first demonstrated that polymorphism of miRNA499 is
associated with oral cancer.
Previous studies have found that miRNA146a may contribute to
the tumor progression, metastasis, prognosis, and survival in
gastric cancer and oral cancer [25,26]. Another finding also
showed that miRNA146a polymorphism can regulate miR-
NA146a expression [27]. Several laboratory studies have also
discovered that miRNA146a could inhibit cell differentiation and
survival in the hematopoietic system [28]. Moreover, connected to
cancer, miRNA146a could suppress cell invasion in pancreatic
cancer [29]. In detail, some evidence connects miRNA146a with
transcription factors such as NF-kB [30]. These findings provide a
new vision that miRNA146a could affect cancer progression by
regulating cell differentiation but may not affect apoptosis.
Although we found no association between miRNA146a and
several clinical statuses in our study, based on these findings, future
studies could consider joint prognosis status or even survival rate.
Recent studies have identified that miRNA196 may interact
with several transcription factors and involve in cancer develop-
ment and progression [31,32]. Some findings suggest that
overexpression of miRNA196 leads to more favorable prognosis
and survival in leukemia [33]. In addition, miRNA196 is
associated with inflammation in specific cancers [34]. Further-
more, Christensen et al., reports a polymorphism in the mature
sequence of miRNA196a2 in a case-control study (n=1,039) of
head and neck squamous cell carcinoma (HNSCC) [35]. When
the authors stratified on tumor site they did not observe a
significant association between oral cancer and miRNA196a2,
though the effect estimate was protective, similar to the results
presented in this study. Although the reason for those discrepan-
cies is not well-known, the different results from the report and the
present study may relate to the racial/ethnic difference.
Considering that the causes of carcinomas are complex, we
analyzed several risk factors, such as smoking status and betel nut
chewing habits, in this study. We expect that these gene
polymorphisms could influence the susceptibility of oral cancer.
Based on the results, we observed that these polymorphisms
significantly increased the odds ratio in each group, possibly
because the functions of these miRNAs regulate the differentia-
tions and proliferations in tumor progression. We also found that
genetic polymorphism of miRNA499 is associated with distal
metastasis of OSCC. A previous study for colorectal cancer has
found that overexpression of miRNA499 may facilitate the
migration and invasion of cancer cells in vitro, as well as the
metastasis to lung and liver in vivo [36]. Additionally, this study
also identified forkhead box O4 (FOXO4) and programmed cell
death 4 (PDCD4) as direct and functional targets of miRNA499
[36]. Moreover, Reis et al., also reports that PDCD4 as a
suppressor of migration and invasion and may be a clinically
relevant biomarker with prognostic value in OSCC [37]. These
abovementioned findings may provide a preliminary explanation
with our finding for the association between miRNA499 and distal
metastasis of OSCC. Detailed relevant mechanisms may warrant
further studies.
One of the limitations of our study is that information on
alcohol, betel nut, and tobacco use is dichotomized into ‘‘ever-
user’’ versus ‘‘never-user.’’ As the result, more detailed analysis
based on amount, length, and past history of betel nut, alcohol,
and tobacco consumption were not able to be performed. Data
collection relied on self-reports, for which some individuals may be
reluctant to report their habitual use of such substances. Hence,
there may be residual confounding effect from betel nut, alcohol,
and tobacco use misclassification. Furthermore, the functional role
of miRNA in growth or metastasis of oral cancer is worth for
further investigation, which will be included in our future work.
Clones containing various genotypes of miRNA499 SNPs will be
constructed to elucidate the possible functions of miRNA499
(proliferation, cell cycle regulation, migration and invasion) in oral
cancer cell lines, as well as the underlying mechanisms.
Furthermore, this study revealed the nonconformity of miRNA
149 (rs2292832) genotypes to Hardy-Weinberg equilibrium in the
control group. A previous study with 107000 genotypes generated
from 443 SNPs has found that genotype distributions for 36 out of
313 assays (11.5%) were deviated from HWE (P,0.05) [38]. Upon
searching for the possible reasons, assays for SNPs proved
nonspecific or genotyping errors have been identified. However,
they also found the deviation from HWE for the remaining 10
SNPs was unexplainable. Although the reason for the nonconfor-
mity of miRNA 149 genotypes to HWE in our control group is not
explored yet, results from the abovementioned study may provide
some direction for our future study.
In conclusion, we discovered a significant association between
miRNA499 gene polymorphisms and the susceptibility of oral
cancer. However, there are no connections between the SNPs and
clinical status. After considering betel nut chewing, which is the
most influential factor of oral cancer, we found that those four
miRNAs which carrying the mutation genotype may increase the
susceptibility of oral cancer. These gene mutations may affect
miRNA target efficiency and stability and increase the incidence of
oral cancer, but the detailed mechanisms from gene levels to
protein levels that ultimately affect tumor development should be
classified, perhaps charting a new direction for target therapy.
Materials and Methods
Subjects and Specimen Collection
We recruited 470 male patients at Chung Shan Medical
University Hospital in Taichung and Changhua Christian
Hospital and Show Chwan Memorial Hospital in Changhua,
Taiwan as a case group between 2007 and 2011. Meanwhile,
controls were enrolled from the physical examination during those
three hospitals, which are also the facilities that cases were
collected from. At the end of recruitment, a total of 425 male
participants that had neither self reported history of cancer of any
sites were included. In addition, subjects with oral precancerous
disease such as oral submucous fibrosis, leukoplakia, erythroplakia,
verrucous hyperplasia, etc. were excluded from control group. The
participation rate was approximately 91% for cases and 76% for
controls. Since all cases and controls were consecutively collected
without any selection, and based on information provided on
questionnaires, no significant genetic relationship or family history
were found.
As for cases and controls, exposure information, including betel
quid chewing (ever- vs. never-user), tobacco use (smoker vs. non-
smoker) and alcohol consumption (current heavy drinker, defined
by CDC as consuming an average of more than 2 drinks per day
MicroRNA Gene Polymorphisms in Oral Cancer
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naires. While medical information of cases, including TMN
clinical staging, primary tumor size, lymph node involvement and
histologic grade, were obtained from medical records. Oral cancer
patients were staged clinically at the time of diagnosis according to
the TNM staging system of the American Joint Committee on
Cancer (AJCC) [39]. Tumor differentiation examined by pathol-
ogist according to AJCC classification. This study has been
reviewed and approved by Institutional Review Board and
informed written consent was obtained from each individual.
DNA Extraction
The whole blood samples, collected from healthy controls and
oral cancer patients, were placed into tubes containing EDTA,
after centrifuged and stored at 280uC. Venous blood from each
subject was drawn into vacutainer tubes containing EDTA and
stored at 4uC. Genomic DNA was extracted by QIAamp DNA
blood mini kits (Qiagen, Valencia, USA) according to the
manufacture’s instructions. DNA was dissolved in TE buffer
[10 mM Tris (PH 7.8), 1 mM EDTA] and then quantitated by a
measurement of OD260. Final preparation was stored at 220uC
and used as templates for polymerase chain reaction.
Polymerase Chain Reaction-restriction Fragment Length
Polymorphism (PCR-RFLP)
The miRNAs gene rs2910164, rs11614913, and rs3746444
polymorphisms were determined by PCR-RFLP assay [15]. The
primers sequences and the restriction enzyme for analysis of those
miRNAs gene polymorphisms were described in Table S5. PCR
was performed in total 10 ml volume containing 100 ng DNA
template, 1.0 mlo f1 0 6 PCR buffer (Invitrogen, Carslbad, CA,
USA), 0.25 U of Taq DNA polymerase (Invitrogen), 0.2 mM
dNTPs (Promega, Madison, WI, USA) and 200 nM of each
primer (MDBio Inc. Taipei, Taiwan). The PCR cycling conditions
were 5 min at 94uC followed by 35 cycles of 1 min at 94uC, 1
minat 58uC for miRNA146a, 1 min at 63uC for miRNA196a2,
and 1 min at 67uC for miRNA499, and 2 min at 72uC, with a
final step at 72uC for 20 min to allow a complete extension of all
PCR fragments. The results were shown in Figure 1. For each
assay, appropriate controls (nontemplate and known genotype)
were included in each typing run to monitor reagent contamina-
tion. To validate results from PCR-RFLP and for quality control,
around 10% of assays were repeated from different batches and
several cases of each genotype were confirmed by the DNA
sequence analysis.
Real-time PCR
The allelic discrimination of the miRNA149 rs2292832 gene
polymorphisms was assessed with the ABI StepOne
TM Real-Time
PCR System (Applied Biosystems) and analyzed using SDS v3.0
software (Applied Biosystems), using the TaqMan assay. The final
volume for each reaction was 5 mL, containing 2.5 mL TaqMan
Genotyping Master Mix, 0.125 mL TaqMan probes mix, and
10 ng genomic DNA. The real-time PCR reaction included an
initial denaturation step at 95uC for 10 min, followed by 40 cycles,
each consisting of 95uC for 15 sec and 60uC for 1 min.
Statistical Analysis
The distributions of demographic characteristics and genotype
frequencies between cases and controls as well as clinicopatholog-
ical features in different genotypes were analyzed by Fisher’s exact
test, since the small sample size was present in some categories of
variables. The odds ratios (ORs) with their 95% confidence
intervals (CIs) of the association between genotype frequencies and
oral cancer were estimated by multiple logistic regression models,
after controlling for covariates. Nonparametric method was used
due to not normal distribution of some estimated variables. We
fitted a logistic regression model with main effects (miRNAs
genetic polymorphism, smoking status and betel quid chewing
status), as well as an interaction term between them (miRNAs
genotypes*demographic characteristic), comparing the model
against a model with only the main effects. Interaction effect
was defined as the difference of their deviance, and further
assessed using the likelihood ratio test to calculate x
2 and p values
[40]. A p value of less than 0.05 was considered significant. The
data were analyzed on R statistical software.
Supporting Information
Table S1 Association of miRNA genotype and betel nut
chewing status.
(DOC)
Table S2 Association of miRNA genotype and smoking
status.
(DOC)
Figure 1. Polymerase chain reaction-restriction fragment
length polymorphism of miRNA146a (rs2910164), miRNA196
(rs11614913), miRNA499 (rs3746444) gene. (A) For miRNA146a
rs2910164 gene polymorphism, the wild type homozygous alleles (C/C)
yielded a 25 and 122-bp products, the heterozygous alleles (C/G)
yielded 25-, 122- and 147-bp products, while the mutated type
homozygous alleles (G/G) yielded a 147-bp product. (B) For miRNA196
(rs11614913) gene polymorphism, the wild type homozygous alleles (T/
T) yielded a 149-bp product, the heterozygous alleles (C/T) yielded 24-,
125- and 149-bp products, while the mutated type homozygous alleles
(C/C) yielded a 24- and 125-bp products (C) For miRNA499 (rs3746444)
gene polymorphism, the wild type (T/T) yielded 26- and 120-bp
products; the heterozygous alleles (C/T) yielded 26-, 120- and 146-bp
products, while the mutated type homozygous alleles (C/C) yielded a
146-bp product.
doi:10.1371/journal.pone.0039777.g001
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genotypes in oral cancer patients (#60 only, N=332).
(DOC)
Table S4 Relationship of clinical status and miRNA499
genotypes in oral cancer patients (.60 only, N=138).
(DOC)
Table S5 Primer sequences and PCR conditions for
amplification of miRNA SNPs.
(DOC)
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